Seer, Inc. (SEER)Healthcare | Biotechnology | Redwood City, United States | NasdaqGS
2.00 USD
-0.05
(-2.439%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.03 +0.03 (1.405%) ⇧ (April 17, 2026, 6:47 p.m. EDT) Short-term: ★★★★★ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 5:46 p.m. EDT
Seer Inc. is a classic high-stakes M&A play masquerading as a standard equity trade. The fundamental metrics are a disaster for a long-term hold, with negative earnings, negative free cash flow, and a P/S ratio of 6.8 on minimal revenue growth, yet the stock has rallied nearly 20% in two weeks solely on an unsolicited $2.25 takeover bid. The data screams 'M&A Arbitrage': speculators are dumping capital into near-dated calls to capture the spread between the current ~$2.00 price and the $2.25 offer, while the forecast model's negative predictive direction is rendered irrelevant by the binary event risk of a proxy battle or acquisition. Do not buy this for fundamentals; buy it only if you are confident the board rejects the offer or the deal closes, though the current momentum is heavily weighted toward a deal completion. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.074115 |
| AutoARIMA | 0.074145 |
| AutoETS | 0.074640 |
| AutoTheta | 0.074756 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 54% |
| H-stat | 2.87 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.104 |
| Excess Kurtosis | -0.79 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.121 |
| Revenue per Share | 0.289 |
| Market Cap | 112,841,544 |
| Forward P/E | -1.90 |
| Beta | 1.60 |
| Website | https://seer.bio |
As of April 18, 2026, 5:46 p.m. EDT: Options flow is overwhelmingly skewed towards call speculation, particularly in the April 17 expiration where OTM volume of 100 contracts and 607 open interest at the $2.50 strike (25% OTM) signal a strong market expectation of a surge. The significant open interest at $2.50 aligns with the acquisition offer price of $2.25, indicating traders are positioning for a breakout above the offer. Implied Volatility for calls (3.31) is elevated compared to puts (4.19), but the sheer volume disparity (100 call vol vs 3 put vol) suggests aggressive bullish positioning. The May and July expirations also show concentrated OTM call interest, reinforcing a multi-month bullish bias driven by the takeover narrative.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.015228391 |
| Address1 | 3,800 Bridge Parkway |
| Address2 | Suite 102 |
| All Time High | 86.55 |
| All Time Low | 1.455 |
| Ask | 2.02 |
| Ask Size | 2 |
| Audit Risk | 4 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 605,620 |
| Average Daily Volume3 Month | 342,670 |
| Average Volume | 342,670 |
| Average Volume10Days | 605,620 |
| Beta | 1.598 |
| Bid | 1.99 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 4.612 |
| City | Redwood City |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.0 |
| Current Ratio | 12.844 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.05 |
| Day Low | 1.97 |
| Debt To Equity | 9.121 |
| Display Name | Seer |
| Earnings Call Timestamp End | 1,772,141,400 |
| Earnings Call Timestamp Start | 1,772,141,400 |
| Earnings Timestamp | 1,772,139,600 |
| Earnings Timestamp End | 1,778,616,000 |
| Earnings Timestamp Start | 1,778,616,000 |
| Ebitda | -71,888,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.687 |
| Enterprise To Revenue | -2.98 |
| Enterprise Value | -49,403,456 |
| Eps Current Year | -1.08 |
| Eps Forward | -1.05 |
| Eps Trailing Twelve Months | -1.28 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.8283 |
| Fifty Day Average Change | 0.1717 |
| Fifty Day Average Change Percent | 0.09391238 |
| Fifty Two Week Change Percent | 1.5228391 |
| Fifty Two Week High | 2.41 |
| Fifty Two Week High Change | -0.4100001 |
| Fifty Two Week High Change Percent | -0.17012452 |
| Fifty Two Week Low | 1.65 |
| Fifty Two Week Low Change | 0.35000002 |
| Fifty Two Week Low Change Percent | 0.21212123 |
| Fifty Two Week Range | 1.65 - 2.41 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,607,092,200,000 |
| Float Shares | 37,542,946 |
| Forward Eps | -1.05 |
| Forward P E | -1.904762 |
| Free Cashflow | -27,648,000 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 124 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.51062 |
| Gross Profits | 8,465,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09783 |
| Held Percent Institutions | 0.55341 |
| Implied Shares Outstanding | 56,420,772 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,020-12-04 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. |
| Long Name | Seer, Inc. |
| Market | us_market |
| Market Cap | 112,841,544 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_548496461 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -73,600,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 113,405,751 |
| Open | 2.05 |
| Operating Cashflow | -44,448,000 |
| Operating Margins | -4.1383 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 650 453 0000 |
| Post Market Change | 0.028100014 |
| Post Market Change Percent | 1.4050007 |
| Post Market Price | 2.0281 |
| Post Market Time | 1,776,466,064 |
| Previous Close | 2.05 |
| Price Eps Current Year | -1.8518518 |
| Price Hint | 4 |
| Price To Book | 0.43365136 |
| Price To Sales Trailing12 Months | 6.8067045 |
| Profit Margins | 0.0 |
| Quick Ratio | 12.227 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.05 |
| Regular Market Change Percent | -2.43902 |
| Regular Market Day High | 2.05 |
| Regular Market Day Low | 1.97 |
| Regular Market Day Range | 1.97 - 2.05 |
| Regular Market Open | 2.05 |
| Regular Market Previous Close | 2.05 |
| Regular Market Price | 2.0 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 537,006 |
| Return On Assets | -0.14711 |
| Return On Equity | -0.25082 |
| Revenue Growth | 0.05 |
| Revenue Per Share | 0.289 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 56,420,772 |
| Shares Percent Shares Out | 0.012999999 |
| Shares Short | 732,581 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 904,811 |
| Short Name | Seer, Inc. |
| Short Percent Of Float | 0.0134000005 |
| Short Ratio | 2.8 |
| Source Interval | 15 |
| State | CA |
| Symbol | SEER |
| Total Cash | 185,896,992 |
| Total Cash Per Share | 3.295 |
| Total Debt | 23,652,000 |
| Total Revenue | 16,578,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.28 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.995625 |
| Two Hundred Day Average Change | 0.004374981 |
| Two Hundred Day Average Change Percent | 0.002192286 |
| Type Disp | Equity |
| Volume | 537,006 |
| Website | https://seer.bio |
| Zip | 94,065 |